A Better Real World Practice for Pemetrexed in First-Line Treatment of Advanced Mon-Squamous Non-Small Cell Lung Cancer

被引：0
|
作者：
Zhang, Y. [1 ]
Yan, B. [1 ]
Yang, H. [1 ]
Yang, N. [1 ]
机构：
[1] Hunan Canc Hosp, Changsha, Hunan, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
pemetrexed; Efficacy and safety; nonsquamous non-small-cell lung cancer;
D O I：
10.1016/j.jtho.2018.08.969
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.15-36
引用
收藏
页码：S627 / S627
页数：1
相关论文
共 50 条
  • [21] Study of Gefitinib and Pemetrexed as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation
    An, Chaolun
    Zhang, Jiajun
    Chu, Hongjun
    Gu, Chunyan
    Xiao, Feng
    Zhu, Fengwei
    Lu, Rujian
    Shi, Hai
    Zhang, Hongfei
    Yi, Xin
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (04) : 763 - 768
  • [22] EFFICACY AND SAFETY OF CISPLATIN/PEMETREXED AS FIRST-LINE TREATMENT FOR JAPANESE PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
    Yamaguchi, Teppei
    Nakanishi, Toru
    Hayashi, Masamichi
    Isogai, Sumito
    Hoshino, Tami
    Mieno, Yuki
    Uozu, Sakurako
    Morishita, Mariko
    Okamura, Takuya
    Takeyama, Tomoko
    Minezawa, Tomoyuki
    Morikawa, Sayako
    Niwa, Yoshikazu
    Okazawa, Mitsushi
    Imaizumi, Kazuyoshi
    RESPIROLOGY, 2013, 18 : 83 - 83
  • [23] PEMETREXED MAINTENANCE TREATMENT IN ADVANCED NON SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Megaiz, Ahlem
    Bousahba, Abdelkader
    Rabah, Aicha
    Zemmour, Amel
    Ahed-Messaoud, Malika
    Ghazli, Soumia
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S588 - S589
  • [24] Effectiveness and safety of pembrolizumab as first-line treatment for non-small cell lung cancer in real clinical practice
    Romero-Ventosa, Elena Yaiza
    Garcia-Beloso, Nerea
    Lopez-Lopez, Aida
    Martinez-Lopez-de-Castro, Noemi
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [25] Pemetrexed as the first-line therapy for Chinese patients with advanced non-squamous non-small-cell lung cancer
    Xu, Bei
    Liu, Peng
    Yin, Yongmei
    Liu, Ping
    Shu, Yongqian
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (08) : 763 - 769
  • [26] Real-World Experience of First-Line Afatinib Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer
    Liam, C.
    Ho, G.
    Chai, C.
    Alip, A. Bt
    Pang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S998 - S999
  • [27] Pemetrexed for treatment of advanced non-small cell lung cancer
    Fossella, FV
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 100 - 105
  • [28] Immunochemotherapy as First-line Treatment for Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancers
    Huang, Shujie
    Gao, Zhen
    Qiao, Guibin
    JAMA ONCOLOGY, 2021, 7 (10) : 1580 - 1580
  • [29] Pembrolizumab for the first-line treatment of non-small cell lung cancer
    Ninomiya, Kiichiro
    Hotta, Katsuyuki
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (10) : 1015 - 1021
  • [30] The Role of Immunotherapy in the First-Line Treatment of Elderly Advanced Non-Small Cell Lung Cancer
    Spagnuolo, Alessia
    Gridelli, Cesare
    CANCERS, 2023, 15 (08)
12345